{"gene":"NPM3","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2004,"finding":"NPM3 physically interacts with B23/nucleophosmin (NPM1) via the N-terminal 35–90 amino acids of B23; this interaction is resistant to RNase and high salt. NPM3 localizes to the nucleolus in an rRNA-transcription-dependent manner. Overexpression of NPM3 decreases pre-rRNA synthesis and processing, and a B23-interaction-defective NPM3 mutant fails to alter pre-rRNA synthesis, establishing that the NPM3–B23 complex inhibits ribosome biogenesis.","method":"Yeast two-hybrid screen; co-immunoprecipitation (endogenous proteins); deletion mutant analysis; nucleolar localization by imaging; pulse-labeling of pre-rRNA in overexpressing cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, deletion mutagenesis, functional rRNA synthesis assay, and nucleolar localization all in one study with clear mechanistic controls","pmids":["15596447"],"is_preprint":false},{"year":2001,"finding":"Human NPM3 protein is localized solely in the nucleus (not cytoplasm), as determined by subcellular fractionation of NIH3T3 cells expressing epitope-tagged NPM3.","method":"Subcellular fractionation of epitope-tagged NPM3-expressing NIH3T3 cells","journal":"BMC genomics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — direct fractionation experiment, single lab, single method, replicated in concept by nucleolar localization shown in PMID:15596447","pmids":["11722795"],"is_preprint":false},{"year":2009,"finding":"NPM3 interacts with transition protein 2 (TP2) during spermiogenesis; acetylation of TP2 at C-terminal lysines by KAT3B (p300) impedes the TP2–NPM3 interaction, linking NPM3's histone chaperone activity to chromatin remodeling during spermatid development.","method":"Co-immunoprecipitation of TP2 and NPM3; in vitro acetylation assay with recombinant proteins; mass spectrometry identification of acetylation sites; CD and AFM to assess DNA condensation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus in vitro biochemical assay with mutagenesis context, single lab, multiple orthogonal methods","pmids":["19710011"],"is_preprint":false},{"year":2012,"finding":"NPM3 alone has minimal sperm chromatin decondensation and nucleosome assembly activity; oligomerization with NPM1 is required to elicit NPM3's nucleosome assembly and sperm chromatin decondensation activity. Additionally, NPM3 suppresses the RNA-binding activity of NPM1, which enhances NPM1 nucleoplasm–nucleolus shuttling in somatic cells.","method":"In vitro sperm chromatin decondensation and nucleosome assembly assays with recombinant human NPM1, NPM2, and NPM3; co-immunoprecipitation; RNA-binding assays; live-cell imaging of NPM1 shuttling","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — reconstituted in vitro biochemical assays plus live-cell imaging plus Co-IP, multiple orthogonal methods, single rigorous study","pmids":["22362753"],"is_preprint":false},{"year":2023,"finding":"PUM1 directly binds and stabilizes NPM3 mRNA; the resulting NPM3 protein interacts with NPM1 to promote NPM1 nuclear translocation, which increases PD-L1 transcription in gastric cancer cells, thereby driving immune escape.","method":"RNA immunoprecipitation (RIP) of PUM1 on NPM3 mRNA; RNA stability assay; co-immunoprecipitation of NPM3 and NPM1; Western blot; ChIP for NPM1 at PD-L1 promoter; in vitro and in vivo T-cell killing assays with knockdown/overexpression","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RIP, Co-IP, ChIP, and functional assays in one study; single lab, multiple orthogonal methods","pmids":["38029539"],"is_preprint":false},{"year":2026,"finding":"NPM3 functions as a lactyltransferase that catalyzes histone H3K18 and H3K27 lactylation; this activity activates FASN transcription and triggers necroptosis in diabetic cardiomyopathy. Dihydroartemisinin (DHA) inhibits NPM3 lactyltransferase activity by competing with lactate for NPM3 binding sites, reducing H3K18la and H3K27la and alleviating necroptosis.","method":"In vivo male DCM mouse model; NPM3 knockdown/overexpression; histone lactylation profiling; FASN ChIP; in vitro lactyltransferase activity assay; DHA competition binding assay; cardiac function readouts","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — novel enzymatic activity (lactyltransferase) supported by in vivo and in vitro assays in a single study; single lab, not yet independently replicated","pmids":["41803151"],"is_preprint":false}],"current_model":"NPM3 is a nuclear/nucleolar chaperone that forms a complex with NPM1/B23 to inhibit ribosome biogenesis, facilitates sperm chromatin remodeling and nucleosome assembly in an NPM1-dependent manner (also suppressing NPM1 RNA-binding to enhance its nuclear shuttling), interacts with transition protein TP2 during spermatogenesis (an interaction disrupted by TP2 acetylation), promotes PD-L1-mediated immune escape via NPM1 nuclear translocation in cancer cells, and in a recent report acts as a lactyltransferase catalyzing histone H3K18/H3K27 lactylation to drive FASN transcription and necroptosis in diabetic cardiomyopathy."},"narrative":{"mechanistic_narrative":"NPM3 is a nuclear histone chaperone that functions largely through partnership with NPM1/B23 to regulate ribosome biogenesis and chromatin remodeling [PMID:15596447, PMID:22362753]. It binds B23/NPM1 directly via the B23 N-terminus in an RNase- and salt-resistant manner, localizes to the nucleolus in an rRNA-transcription-dependent fashion, and the NPM3–B23 complex represses pre-rRNA synthesis and processing [PMID:15596447]. On its own NPM3 has minimal nucleosome assembly and sperm chromatin decondensation activity; oligomerization with NPM1 is required to elicit these chaperone activities, and NPM3 reciprocally suppresses the RNA-binding activity of NPM1 to enhance NPM1 nucleoplasm-to-nucleolus shuttling [PMID:22362753]. During spermiogenesis NPM3 interacts with transition protein TP2, an interaction blocked by p300/KAT3B-mediated acetylation of TP2, coupling NPM3 chaperone function to spermatid chromatin remodeling [PMID:19710011]. In gastric cancer NPM3 mRNA is stabilized by PUM1, and NPM3 promotes NPM1 nuclear translocation to drive PD-L1 transcription and immune escape [PMID:38029539]. A separate report assigns NPM3 a lactyltransferase activity catalyzing histone H3K18 and H3K27 lactylation to activate FASN transcription and necroptosis in diabetic cardiomyopathy [PMID:41803151].","teleology":[{"year":2001,"claim":"Established the basic subcellular distribution of human NPM3, the first step in placing it in a functional compartment.","evidence":"Subcellular fractionation of epitope-tagged NPM3 in NIH3T3 cells","pmids":["11722795"],"confidence":"Medium","gaps":["Single method, single cell line","Does not resolve nucleolar versus nucleoplasmic localization or condition-dependence"]},{"year":2004,"claim":"Answered how NPM3 acts in the nucleus by showing it binds B23/NPM1 and the complex represses ribosome biogenesis, defining its first molecular function and partner.","evidence":"Yeast two-hybrid, reciprocal Co-IP, deletion mapping, rRNA-dependent nucleolar imaging, and pre-rRNA pulse-labeling in overexpressing cells","pmids":["15596447"],"confidence":"High","gaps":["Mechanism by which the complex inhibits pre-rRNA synthesis not resolved","Stoichiometry and structure of the NPM3–B23 complex not defined"]},{"year":2009,"claim":"Linked NPM3 chaperone activity to a developmental program by identifying its interaction with TP2 and showing acetylation regulates the interaction.","evidence":"Co-IP of TP2 and NPM3, in vitro p300 acetylation with MS site mapping, and CD/AFM DNA condensation assays","pmids":["19710011"],"confidence":"Medium","gaps":["In vivo requirement during spermiogenesis not established","Functional consequence of disrupting the TP2–NPM3 interaction for chromatin not directly tested in vivo"]},{"year":2012,"claim":"Resolved the activity dependency by demonstrating NPM3 requires NPM1 oligomerization for nucleosome assembly/decondensation while reciprocally tuning NPM1 RNA binding and shuttling.","evidence":"Reconstituted in vitro chromatin decondensation and nucleosome assembly assays with recombinant NPM proteins, Co-IP, RNA-binding assays, and live-cell NPM1 shuttling imaging","pmids":["22362753"],"confidence":"High","gaps":["Structural basis of NPM3–NPM1 heterooligomerization not defined","Cellular contexts where NPM3 modulates NPM1 shuttling not enumerated"]},{"year":2023,"claim":"Extended NPM3 into a disease pathway by showing PUM1-mediated mRNA stabilization drives NPM3-dependent NPM1 nuclear translocation and PD-L1-mediated immune escape in gastric cancer.","evidence":"RIP, RNA stability assay, Co-IP, ChIP at the PD-L1 promoter, and T-cell killing assays with knockdown/overexpression in vitro and in vivo","pmids":["38029539"],"confidence":"Medium","gaps":["Direct mechanism by which NPM3 promotes NPM1 nuclear translocation not defined","Single tumor type and single lab"]},{"year":2026,"claim":"Proposed an entirely new enzymatic identity for NPM3 as a histone lactyltransferase driving FASN transcription and necroptosis in diabetic cardiomyopathy.","evidence":"DCM mouse model with NPM3 knockdown/overexpression, histone lactylation profiling, FASN ChIP, in vitro lactyltransferase assay, and DHA competition binding","pmids":["41803151"],"confidence":"Medium","gaps":["Novel lactyltransferase activity not independently replicated","Catalytic mechanism and active-site basis for lactyltransfer not structurally defined","Reconciliation of an enzymatic activity with the chaperone/adaptor functions established earlier"]},{"year":null,"claim":"How NPM3's chaperone/adaptor roles relate to its reported lactyltransferase enzymatic activity, and whether these reflect one protein with multiple functions, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model unifying the chaperone and enzymatic claims","No independent confirmation of catalytic lactyltransferase activity"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[2,3]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,3,4]}],"localization":[{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[0]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[1]}],"pathway":[{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0]}],"complexes":[],"partners":["NPM1","TP2","PUM1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O75607","full_name":"Nucleoplasmin-3","aliases":[],"length_aa":178,"mass_kda":19.3,"function":"Plays a role in the regulation of diverse cellular processes such as ribosome biogenesis, chromatin remodeling or protein chaperoning (PubMed:20073534, PubMed:22362753). Modulates the histone chaperone function and the RNA-binding activity of nucleolar phosphoprotein B23/NPM (PubMed:22362753). Efficiently mediates chromatin remodeling when included in a pentamer containing NPM3 and NPM (PubMed:15596447)","subcellular_location":"Nucleus; Nucleus, nucleolus","url":"https://www.uniprot.org/uniprotkb/O75607/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NPM3","classification":"Not Classified","n_dependent_lines":134,"n_total_lines":1208,"dependency_fraction":0.11092715231788079},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000107833","cell_line_id":"CID000860","localizations":[{"compartment":"nucleolus_gc","grade":3}],"interactors":[{"gene":"NPM1","stoichiometry":10.0},{"gene":"RPL13A;RPL13A","stoichiometry":10.0},{"gene":"RPS8","stoichiometry":4.0},{"gene":"RPL15","stoichiometry":4.0},{"gene":"RPS20","stoichiometry":4.0},{"gene":"SSR4","stoichiometry":4.0},{"gene":"RPL6","stoichiometry":4.0},{"gene":"RPL17;RPL17-C18ORF32","stoichiometry":4.0},{"gene":"RPS3A","stoichiometry":4.0},{"gene":"RPL28","stoichiometry":4.0}],"url":"https://opencell.sf.czbiohub.org/target/CID000860","total_profiled":1310},"omim":[{"mim_id":"619545","title":"HYPOPLASTIC FEMURS AND PELVIS; HYPOFP","url":"https://www.omim.org/entry/619545"},{"mim_id":"606456","title":"NUCLEOPHOSMIN/NUCLEOPLASMIN FAMILY, MEMBER 3; NPM3","url":"https://www.omim.org/entry/606456"},{"mim_id":"600483","title":"FIBROBLAST GROWTH FACTOR 8; FGF8","url":"https://www.omim.org/entry/600483"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoli","reliability":"Approved"},{"location":"Actin filaments","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/NPM3"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"O75607","domains":[{"cath_id":"2.60.120.340","chopping":"31-141","consensus_level":"high","plddt":96.5227,"start":31,"end":141}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O75607","model_url":"https://alphafold.ebi.ac.uk/files/AF-O75607-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O75607-F1-predicted_aligned_error_v6.png","plddt_mean":79.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NPM3","jax_strain_url":"https://www.jax.org/strain/search?query=NPM3"},"sequence":{"accession":"O75607","fasta_url":"https://rest.uniprot.org/uniprotkb/O75607.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O75607/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O75607"}},"corpus_meta":[{"pmid":"15596447","id":"PMC_15596447","title":"Protein NPM3 interacts with the multifunctional nucleolar protein B23/nucleophosmin and inhibits ribosome biogenesis.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15596447","citation_count":73,"is_preprint":false},{"pmid":"22362753","id":"PMC_22362753","title":"Function of homo- and hetero-oligomers of human nucleoplasmin/nucleophosmin family proteins NPM1, NPM2 and NPM3 during sperm chromatin remodeling.","date":"2012","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/22362753","citation_count":61,"is_preprint":false},{"pmid":"9177783","id":"PMC_9177783","title":"Npm3: a novel, widely expressed gene encoding a protein related to the molecular chaperones nucleoplasmin and nucleophosmin.","date":"1997","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9177783","citation_count":32,"is_preprint":false},{"pmid":"11722795","id":"PMC_11722795","title":"Cloning, expression and nuclear localization of human NPM3, a member of the nucleophosmin/nucleoplasmin family of nuclear chaperones.","date":"2001","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/11722795","citation_count":29,"is_preprint":false},{"pmid":"38029539","id":"PMC_38029539","title":"Pumilio1 regulates NPM3/NPM1 axis to promote PD-L1-mediated immune escape in gastric cancer.","date":"2023","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/38029539","citation_count":23,"is_preprint":false},{"pmid":"19710011","id":"PMC_19710011","title":"Acetylation of transition protein 2 (TP2) by KAT3B (p300) alters its DNA condensation property and interaction with putative histone chaperone NPM3.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19710011","citation_count":17,"is_preprint":false},{"pmid":"39300184","id":"PMC_39300184","title":"Characterization of the AGR2-NPM3 axis uncovers the AGR2 involvement in PD-L1 regulation in colorectal cancer.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39300184","citation_count":1,"is_preprint":false},{"pmid":"41205056","id":"PMC_41205056","title":"DCN, NPM3 and SULF1 are hub genes related to vasculogenic mimicry in lung adenocarcinoma.","date":"2025","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41205056","citation_count":0,"is_preprint":false},{"pmid":"41803151","id":"PMC_41803151","title":"NPM3 functions as a lactyltransferase to promote necroptosis in male diabetic cardiomyopathy mice models via FASN transcription modulation.","date":"2026","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/41803151","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":6528,"output_tokens":1771,"usd":0.023075,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8620,"output_tokens":2436,"usd":0.052,"stage2_stop_reason":"end_turn"},"total_usd":0.075075,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"NPM3 physically interacts with B23/nucleophosmin (NPM1) via the N-terminal 35–90 amino acids of B23; this interaction is resistant to RNase and high salt. NPM3 localizes to the nucleolus in an rRNA-transcription-dependent manner. Overexpression of NPM3 decreases pre-rRNA synthesis and processing, and a B23-interaction-defective NPM3 mutant fails to alter pre-rRNA synthesis, establishing that the NPM3–B23 complex inhibits ribosome biogenesis.\",\n      \"method\": \"Yeast two-hybrid screen; co-immunoprecipitation (endogenous proteins); deletion mutant analysis; nucleolar localization by imaging; pulse-labeling of pre-rRNA in overexpressing cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, deletion mutagenesis, functional rRNA synthesis assay, and nucleolar localization all in one study with clear mechanistic controls\",\n      \"pmids\": [\"15596447\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Human NPM3 protein is localized solely in the nucleus (not cytoplasm), as determined by subcellular fractionation of NIH3T3 cells expressing epitope-tagged NPM3.\",\n      \"method\": \"Subcellular fractionation of epitope-tagged NPM3-expressing NIH3T3 cells\",\n      \"journal\": \"BMC genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — direct fractionation experiment, single lab, single method, replicated in concept by nucleolar localization shown in PMID:15596447\",\n      \"pmids\": [\"11722795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NPM3 interacts with transition protein 2 (TP2) during spermiogenesis; acetylation of TP2 at C-terminal lysines by KAT3B (p300) impedes the TP2–NPM3 interaction, linking NPM3's histone chaperone activity to chromatin remodeling during spermatid development.\",\n      \"method\": \"Co-immunoprecipitation of TP2 and NPM3; in vitro acetylation assay with recombinant proteins; mass spectrometry identification of acetylation sites; CD and AFM to assess DNA condensation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus in vitro biochemical assay with mutagenesis context, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"19710011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"NPM3 alone has minimal sperm chromatin decondensation and nucleosome assembly activity; oligomerization with NPM1 is required to elicit NPM3's nucleosome assembly and sperm chromatin decondensation activity. Additionally, NPM3 suppresses the RNA-binding activity of NPM1, which enhances NPM1 nucleoplasm–nucleolus shuttling in somatic cells.\",\n      \"method\": \"In vitro sperm chromatin decondensation and nucleosome assembly assays with recombinant human NPM1, NPM2, and NPM3; co-immunoprecipitation; RNA-binding assays; live-cell imaging of NPM1 shuttling\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — reconstituted in vitro biochemical assays plus live-cell imaging plus Co-IP, multiple orthogonal methods, single rigorous study\",\n      \"pmids\": [\"22362753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PUM1 directly binds and stabilizes NPM3 mRNA; the resulting NPM3 protein interacts with NPM1 to promote NPM1 nuclear translocation, which increases PD-L1 transcription in gastric cancer cells, thereby driving immune escape.\",\n      \"method\": \"RNA immunoprecipitation (RIP) of PUM1 on NPM3 mRNA; RNA stability assay; co-immunoprecipitation of NPM3 and NPM1; Western blot; ChIP for NPM1 at PD-L1 promoter; in vitro and in vivo T-cell killing assays with knockdown/overexpression\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RIP, Co-IP, ChIP, and functional assays in one study; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"38029539\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"NPM3 functions as a lactyltransferase that catalyzes histone H3K18 and H3K27 lactylation; this activity activates FASN transcription and triggers necroptosis in diabetic cardiomyopathy. Dihydroartemisinin (DHA) inhibits NPM3 lactyltransferase activity by competing with lactate for NPM3 binding sites, reducing H3K18la and H3K27la and alleviating necroptosis.\",\n      \"method\": \"In vivo male DCM mouse model; NPM3 knockdown/overexpression; histone lactylation profiling; FASN ChIP; in vitro lactyltransferase activity assay; DHA competition binding assay; cardiac function readouts\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — novel enzymatic activity (lactyltransferase) supported by in vivo and in vitro assays in a single study; single lab, not yet independently replicated\",\n      \"pmids\": [\"41803151\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NPM3 is a nuclear/nucleolar chaperone that forms a complex with NPM1/B23 to inhibit ribosome biogenesis, facilitates sperm chromatin remodeling and nucleosome assembly in an NPM1-dependent manner (also suppressing NPM1 RNA-binding to enhance its nuclear shuttling), interacts with transition protein TP2 during spermatogenesis (an interaction disrupted by TP2 acetylation), promotes PD-L1-mediated immune escape via NPM1 nuclear translocation in cancer cells, and in a recent report acts as a lactyltransferase catalyzing histone H3K18/H3K27 lactylation to drive FASN transcription and necroptosis in diabetic cardiomyopathy.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NPM3 is a nuclear histone chaperone that functions largely through partnership with NPM1/B23 to regulate ribosome biogenesis and chromatin remodeling [#0, #3]. It binds B23/NPM1 directly via the B23 N-terminus in an RNase- and salt-resistant manner, localizes to the nucleolus in an rRNA-transcription-dependent fashion, and the NPM3–B23 complex represses pre-rRNA synthesis and processing [#0]. On its own NPM3 has minimal nucleosome assembly and sperm chromatin decondensation activity; oligomerization with NPM1 is required to elicit these chaperone activities, and NPM3 reciprocally suppresses the RNA-binding activity of NPM1 to enhance NPM1 nucleoplasm-to-nucleolus shuttling [#3]. During spermiogenesis NPM3 interacts with transition protein TP2, an interaction blocked by p300/KAT3B-mediated acetylation of TP2, coupling NPM3 chaperone function to spermatid chromatin remodeling [#2]. In gastric cancer NPM3 mRNA is stabilized by PUM1, and NPM3 promotes NPM1 nuclear translocation to drive PD-L1 transcription and immune escape [#4]. A separate report assigns NPM3 a lactyltransferase activity catalyzing histone H3K18 and H3K27 lactylation to activate FASN transcription and necroptosis in diabetic cardiomyopathy [#5].\",\n  \"teleology\": [\n    {\n      \"year\": 2001,\n      \"claim\": \"Established the basic subcellular distribution of human NPM3, the first step in placing it in a functional compartment.\",\n      \"evidence\": \"Subcellular fractionation of epitope-tagged NPM3 in NIH3T3 cells\",\n      \"pmids\": [\"11722795\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single method, single cell line\", \"Does not resolve nucleolar versus nucleoplasmic localization or condition-dependence\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Answered how NPM3 acts in the nucleus by showing it binds B23/NPM1 and the complex represses ribosome biogenesis, defining its first molecular function and partner.\",\n      \"evidence\": \"Yeast two-hybrid, reciprocal Co-IP, deletion mapping, rRNA-dependent nucleolar imaging, and pre-rRNA pulse-labeling in overexpressing cells\",\n      \"pmids\": [\"15596447\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which the complex inhibits pre-rRNA synthesis not resolved\", \"Stoichiometry and structure of the NPM3–B23 complex not defined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Linked NPM3 chaperone activity to a developmental program by identifying its interaction with TP2 and showing acetylation regulates the interaction.\",\n      \"evidence\": \"Co-IP of TP2 and NPM3, in vitro p300 acetylation with MS site mapping, and CD/AFM DNA condensation assays\",\n      \"pmids\": [\"19710011\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo requirement during spermiogenesis not established\", \"Functional consequence of disrupting the TP2–NPM3 interaction for chromatin not directly tested in vivo\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Resolved the activity dependency by demonstrating NPM3 requires NPM1 oligomerization for nucleosome assembly/decondensation while reciprocally tuning NPM1 RNA binding and shuttling.\",\n      \"evidence\": \"Reconstituted in vitro chromatin decondensation and nucleosome assembly assays with recombinant NPM proteins, Co-IP, RNA-binding assays, and live-cell NPM1 shuttling imaging\",\n      \"pmids\": [\"22362753\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of NPM3–NPM1 heterooligomerization not defined\", \"Cellular contexts where NPM3 modulates NPM1 shuttling not enumerated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Extended NPM3 into a disease pathway by showing PUM1-mediated mRNA stabilization drives NPM3-dependent NPM1 nuclear translocation and PD-L1-mediated immune escape in gastric cancer.\",\n      \"evidence\": \"RIP, RNA stability assay, Co-IP, ChIP at the PD-L1 promoter, and T-cell killing assays with knockdown/overexpression in vitro and in vivo\",\n      \"pmids\": [\"38029539\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct mechanism by which NPM3 promotes NPM1 nuclear translocation not defined\", \"Single tumor type and single lab\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Proposed an entirely new enzymatic identity for NPM3 as a histone lactyltransferase driving FASN transcription and necroptosis in diabetic cardiomyopathy.\",\n      \"evidence\": \"DCM mouse model with NPM3 knockdown/overexpression, histone lactylation profiling, FASN ChIP, in vitro lactyltransferase assay, and DHA competition binding\",\n      \"pmids\": [\"41803151\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Novel lactyltransferase activity not independently replicated\", \"Catalytic mechanism and active-site basis for lactyltransfer not structurally defined\", \"Reconciliation of an enzymatic activity with the chaperone/adaptor functions established earlier\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How NPM3's chaperone/adaptor roles relate to its reported lactyltransferase enzymatic activity, and whether these reflect one protein with multiple functions, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model unifying the chaperone and enzymatic claims\", \"No independent confirmation of catalytic lactyltransferase activity\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [2, 3]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 3, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"NPM1\", \"TP2\", \"PUM1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}